Browse by Audience
Skip to content
Papers of the Week
The emerging role of dupilumab in dermatological indications.
Authors
PMID: 33769900.
Abstract
Dupilumab represents a breakthrough in the management of atopic dermatitis (AD), thanks to its powerful T-helper (Th)2-mediated immunity modulating activity. It can reduce the atopic skin molecular signature and induce a significant decrease in the clinical signs and symptoms of AD patients.